Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Other financing activities (2021 - 2025)

Celularity (CELU) has disclosed Other financing activities for 4 consecutive years, with $103000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to $103000.0; the TTM value through Dec 2025 reached $103000.0, changed N/A, while the annual FY2025 figure was $103000.0, N/A changed from the prior year.
  • Other financing activities hit $103000.0 in Q4 2025 for Celularity, down from $260000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $4.8 million in Q1 2021 and bottomed at -$150000.0 in Q4 2022.
  • Average Other financing activities over 4 years is $1.4 million, with a median of $629500.0 recorded in 2021.
  • Year-over-year, Other financing activities plummeted 110.5% in 2022 and then rose 12.55% in 2023.
  • Celularity's Other financing activities stood at $1.4 million in 2021, then plummeted by 110.5% to -$150000.0 in 2022, then skyrocketed by 273.33% to $260000.0 in 2023, then plummeted by 60.38% to $103000.0 in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $103000.0, $260000.0, and -$150000.0 for Q4 2025, Q3 2023, and Q4 2022 respectively.